These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14566830)

  • 1. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis.
    Bruner DW; Moore D; Parlanti A; Dorgan J; Engstrom P
    Int J Cancer; 2003 Dec; 107(5):797-803. PubMed ID: 14566830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.
    Kiciński M; Vangronsveld J; Nawrot TS
    PLoS One; 2011; 6(10):e27130. PubMed ID: 22073129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis.
    Ren ZJ; Cao DH; Zhang Q; Ren PW; Liu LR; Wei Q; Wei WR; Dong Q
    BMC Cancer; 2019 Sep; 19(1):871. PubMed ID: 31477094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer risk prediction based on complete prostate cancer family history.
    Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
    Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
    Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
    Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history and prostate cancer risk in a population-based cohort of Iowa men.
    Cerhan JR; Parker AS; Putnam SD; Chiu BC; Lynch CF; Cohen MB; Torner JC; Cantor KP
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):53-60. PubMed ID: 9950240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history and the risk of breast cancer: a systematic review and meta-analysis.
    Pharoah PD; Day NE; Duffy S; Easton DF; Ponder BA
    Int J Cancer; 1997 May; 71(5):800-9. PubMed ID: 9180149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.
    Sellers TA; Potter JD; Rich SS; Drinkard CR; Bostick RM; Kushi LH; Zheng W; Folsom AR
    J Natl Cancer Inst; 1994 Dec; 86(24):1860-5. PubMed ID: 7990161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of familial prostate cancer risk.
    Johns LE; Houlston RS
    BJU Int; 2003 Jun; 91(9):789-94. PubMed ID: 12780833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-degree family history of prostate cancer is associated the risk of breast cancer and ovarian cancer.
    Zheng Q; Ying Q; Ren Z; Zhang Q; Lu D; Wang H; Wei W
    Medicine (Baltimore); 2021 Jan; 100(4):e23816. PubMed ID: 33530178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family history and risk of fatal prostate cancer.
    Rodríguez C; Calle EE; Miracle-McMahill HL; Tatham LM; Wingo PA; Thun MJ; Heath CW
    Epidemiology; 1997 Nov; 8(6):653-7. PubMed ID: 9345665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family history and the risk of prostate cancer.
    Steinberg GD; Carter BS; Beaty TH; Childs B; Walsh PC
    Prostate; 1990; 17(4):337-47. PubMed ID: 2251225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Risks for Lethal Prostate Cancer Based on Complete Family History of Prostate Cancer Death.
    Albright FS; Stephenson RA; Agarwal N; Cannon-Albright LA
    Prostate; 2017 Jan; 77(1):41-48. PubMed ID: 27527734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.
    Zeegers MP; Jellema A; Ostrer H
    Cancer; 2003 Apr; 97(8):1894-903. PubMed ID: 12673715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.
    Clements MB; Vertosick EA; Guerrios-Rivera L; De Hoedt AM; Hernandez J; Liss MA; Leach RJ; Freedland SJ; Haese A; Montorsi F; Boorjian SA; Poyet C; Ankerst DP; Vickers AJ
    Eur Urol; 2022 Aug; 82(2):163-169. PubMed ID: 34980493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.
    Cannon-Albright LA; Carr SR; Akerley W
    J Thorac Oncol; 2019 Jul; 14(7):1184-1191. PubMed ID: 31075544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at diagnosis and age at death in familial prostate cancer.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy.
    Bova GS; Partin AW; Isaacs SD; Carter BS; Beaty TL; Isaacs WB; Walsh PC
    J Urol; 1998 Sep; 160(3 Pt 1):660-3. PubMed ID: 9720516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.